Heteroaryl substituted beta-hydroxyethylamines for use in treating hyperglycaemia

US12036210B2 · kind B2 · utility

Assignee

• ATROGI AB · SE

Inventors

• Benjamin Pelcman · Stockholm, SE
• Tore Bengtsson · Vaxholm, SE

Key dates

• Filing date: Jan 13, 2022
• Grant date: Jul 16, 2024
• Expiry date: Nov 3, 2042

Classification

• Technology area (CPC C): Chemistry; Metallurgy
• CPC primary: C07D277/28
• WIPO field: Pharmaceuticals
• WIPO sector: Chemistry

Abstract

There is herein provided a compound of formula (I) or a pharmaceutically acceptable salt thereof, wherein the ring containing Q1 to Q5, and the groups R1, R2 and R3, have meanings as provided in the description.